We are live on ! Find out more
WA1

Wimmer Associates 1 Portfolio holdings

AUM $205M
1-Year Est. Return 21.23%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+21.23%
3 Year Est. Return
+69.43%
5 Year Est. Return
+91.58%
10 Year Est. Return
+307.32%
AUM
$109M
AUM Growth
-$14K
Cap. Flow
-$4.32M
Cap. Flow %
-3.98%
Top 10 Hldgs %
25.09%
Holding
113
New
4
Increased
20
Reduced
58
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 14.23%
2 Technology 13.01%
3 Industrials 11.81%
4 Financials 9.82%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
101
Marriott International
MAR
$101B
$245K 0.23%
2,220
BABA icon
102
Alibaba
BABA
$277B
$242K 0.22%
+1,400
New +$227K
VTV icon
103
Vanguard Value ETF
VTV
$190B
$214K 0.2%
2,140
-40
-2% -$3.92K
NKE icon
104
Nike
NKE
$63.5B
$206K 0.19%
3,980
-1,440
-27% -$80.8K
CRIS icon
105
Curis
CRIS
$9.47M
$15K 0.01%
5
ACN icon
106
Accenture
ACN
$100B
-1,720
Closed -$213K
AZN icon
107
AstraZeneca
AZN
$266B
-21,560
Closed -$1.47M
ECL icon
108
Ecolab
ECL
$79.5B
-1,676
Closed -$223K
VNQ icon
109
Vanguard Real Estate ETF
VNQ
$40.2B
-4,525
Closed -$377K
AGN
110
DELISTED
Allergan plc
AGN
-2,575
Closed -$626K
DD
111
DELISTED
Du Pont De Nemours E I
DD
-5,329
Closed -$430K

Similar funds

Wimmer Associates 1's Q3 2017 Portfolio in Review

As of Q3 2017, Wimmer Associates 1 held 113 positions worth $109M, down 0.01% from $109M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wimmer Associates 1 withdrew a net $4.32M in Q3 2017, closing 6 positions and reducing 58 holdings. Its most notable exit was AstraZeneca, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Wimmer Associates 1 opened a new position in Nucor worth $1.32M.

  • Wimmer Associates 1's largest Q3 2017 buy was Nucor: 23,615 shares worth $1.32M.
  • Wimmer Associates 1 added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $768K increase.
  • Wimmer Associates 1's biggest Q3 2017 reduction was Wells Fargo, cutting an estimated $508K.
  • Wimmer Associates 1 fully exited AstraZeneca in Q3 2017, selling an estimated $1.47M.
  • Wimmer Associates 1's ten largest holdings make up 25% of its $109M portfolio in Q3 2017.
  • Wimmer Associates 1 opened 4 new positions and closed 6 in Q3 2017.
  • Wimmer Associates 1's portfolio value fell 0.01% quarter-over-quarter to $109M.

Based on Wimmer Associates 1's 13F filing for Q3 2017, filed 14 Nov 2017.